Biography
Robert S. Warren, M.D. is a Professor of Surgery and a specialist in gastrointestinal and liver cancer. He earned a medical degree at the University of Minnesota, where he completed a general surgery residency. After completing an oncology research fellowship at Memorial Sloan-Kettering Cancer Center in New York, he was an associate physician at Rockefeller University in New York. A board-certified surgeon, Dr. Warren joined UCSF Medical Center in 1988. Highly respected by his peers, Dr. Warren was named to the list of U.S. News "America's Top Doctors," a distinction reserved for the top 1% of physicians in the nation for a given specialty. His research focuses on the biology of colorectal cancer and how it spreads.
Dr. Warren is involved in clinical and laboratory research, which has centered on the biology of colorectal cancer metastasis that includes Vascular Endothelial Growth Factor (VEGF), Insulin-Like Growth Factors and Their Binding Proteins AS Modulators of Growth of Colorectal Cancer Metastases and Cytogenetics of Colorectal Cancer Metastasis. The laboratory work focuses on two areas: 1) autocrine growth factors and angiogenesis in colorectal cancer 2) molecular features which predict clinical outcome in primary and metastatic colorectal cancer.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of Minnesota | M.D. | School of Medicine | 1980 |
Board Certifications
- American Board of Surgery, 1989
Program Affiliations
- Surgical Oncology Program
- Surgical Oncology Laboratory
- UCSF Helen Diller Family Comprehensive Cancer Center
- UCSF Department of Surgery
Grants and Funding
- General Clinical Research Center | NIH | 1974-12-01 - 2009-03-31 | Role: Co-Investigator
- MOLECULAR MARKERS OF PROGNOSIS IN COLON CANCER | NIH | 2000-03-03 - 2006-02-28 | Role: Principal Investigator
- ROLE OF CYTOKINES IN CANCER PATIENTS UNDERGOING SURGERY | NIH | 1993-07-01 - 1999-06-30 | Role: Principal Investigator
Research Narrative
- Biology of colorectal cancer metastasis
- Molecular features which predict clinical outcome in primary and metastatic colorectal cancer
- Autocrine growth factors and angiogenesis in colorectal cancer
- Vascular Endothelial Growth Factor (VEGF) Hypoxia and Colon Cancer
- Insulin-Like Growth Factors and Their Binding Proteins As Modulators of Growth of Colorectal Cancer Metastases
- Cytogenetics of Colorectal Cancer Metastasis
Publications
- Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.| | PubMed
- STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20.| | PubMed
- Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era.| | PubMed
- RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon.| | PubMed
- A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.| | PubMed
- Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.| | PubMed
- Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.| | PubMed
- Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.| | PubMed
- High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.| | PubMed
- RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer.| | PubMed